David Risinger

Stock Analyst at Leerink Partners

(2.64)
# 679
Out of 5,354 analysts
197
Total ratings
59.30%
Success rate
31.08%
Average return
37 Stocks
Name Action PT Current % Upside Ratings Updated
JNJ Johnson & Johnson
Downgrades: Market Perform
169 153
153.87 -0.57% 4 May 13, 2025
VRTX Vertex Pharmaceutica...
Downgrades: Market Perform
550 503
446.54 12.64% 4 May 6, 2025
REGN Regeneron Pharmaceut...
Upgrades: Outperform
762 834
484.03 72.3% 8 Feb 5, 2025
ABBV AbbVie
Upgrades: Outperform
206
188.08 9.53% 7 Nov 22, 2024
BMY Bristol-Myers Squibb
Upgrades: Outperform
55 73
48.12 51.7% 4 Nov 12, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
49 69
22.95 200.65% 2 Nov 11, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
16
5.68 181.69% 1 Oct 24, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
44
n/a n/a 2 Sep 17, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
106 153
34.27 346.45% 2 Sep 3, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
15 10
11.03 -9.34% 3 Aug 6, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
28 2
1.97 1.52% 2 Jul 9, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
47
21.52 118.4% 1 Apr 16, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Outperform
267 318
287.7 10.53% 4 Oct 11, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
6 11
12.93 -14.93% 2 Aug 15, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
410 458
766.71 -40.26% 16 May 1, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
42
53.95 -22.15% 3 Mar 16, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Market Perform
81 91
108.99 -16.51% 3 Feb 3, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Market Perform
49 48
23.39 105.22% 14 Feb 1, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
8 10
11.31 -11.58% 4 Dec 19, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
88 117
n/a n/a 12 Dec 13, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Market Perform
7 10
29.64 -66.26% 2 Jun 24, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Equal-Weight
35 37
9.53 288.25% 2 Feb 22, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Equal-Weight
162 176
110.07 59.9% 3 Apr 1, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Equal-Weight
18 16
8.65 84.97% 1 Mar 10, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Equal-Weight
53 45
26.34 70.84% 7 Mar 5, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Underweight
5 7
n/a n/a 8 Mar 3, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Equal-Weight
22 35
4.65 652.69% 4 Feb 26, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
31 41
13.46 204.61% 5 Nov 24, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Equal-Weight
167 174
168.5 3.26% 9 Nov 13, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Equal-Weight
51
33.52 52.15% 1 Jul 13, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Underweight
13 8
17.5 -54.29% 14 Apr 2, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Equal-Weight
23 18
n/a n/a 12 Apr 2, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
97 89
78.41 13.51% 8 Apr 2, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Equal-Weight
20 16
31.25 -48.8% 6 Apr 2, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Equal-Weight
5 3
7.29 -58.85% 4 Apr 2, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Equal-Weight
156
n/a n/a 8 Jan 30, 2019
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Equal-Weight
14 35
n/a n/a 5 Aug 17, 2018